Cipher Pharmaceuticals Inc.
CPHR
CPHR was delisted on the 8th of December, 2016.
26 hedge funds and large institutions have $51.8M invested in Cipher Pharmaceuticals Inc. in 2014 Q4 according to their latest regulatory filings, with 26 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$15.1M |
| 2 |
RA
Raffles Associates
New York
|
+$7.84M |
| 3 |
TAM
Taylor Asset Management
Toronto,
Ontario, Canada
|
+$7.48M |
| 4 |
IIM
Intact Investment Management
Montreal,
Quebec, Canada
|
+$5.36M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$3.71M |
Top Sellers
CPHR Hedge Fund Activity: Q4 2014 in Review
26 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Cipher Pharmaceuticals Inc. (CPHR) for Q4 2014, worth a combined $51.8M.
Buyers outnumbered sellers: 26 funds opened new CPHR positions and 0 closed out — a net gain of 26 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Acadian Asset Management, opening a new position worth an estimated $15.1M.
- 26 institutional investors held Cipher Pharmaceuticals Inc. (CPHR) as of Q4 2014, up from 0 in Q3 2014.
- Funds reported $51.8M of Cipher Pharmaceuticals Inc. stock for Q4 2014.
- 26 funds opened new Cipher Pharmaceuticals Inc. positions in Q4 2014 and 0 closed out, a net change of +26 holders.
- The largest Cipher Pharmaceuticals Inc. buyer in Q4 2014 was Acadian Asset Management, an estimated $15.1M added.
Based on aggregated 13F filings for Q4 2014.